+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bowel Management Systems Market Size, Share & Trends Analysis Report By Product (Colostomy Bags, Irrigation Systems, Nerve Modulation Devices), By Patient Type, By End Use, And Segment Forecasts, 2018 - 2025

  • ID: 4751789
  • Report
  • December 2018
  • Region: Global
  • 110 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M
  • B. Braun
  • Cogentix Medical
  • Consure
  • Hollister Incorporated
  • Medtronic
  • MORE
The global bowel management system market is expected to reach USD 2.25 billion by 2025, expanding at a CAGR of 3.3% during the forecast period. Rising incidence of fecal incontinence coupled with growing government initiatives to raise awareness about bowel management is likely to drive the market. Furthermore, favorable reimbursement scenario has also been favoring the growth of the market.

Bowel management systems are an important tool to manage fecal incontinence. According to the International Foundation for Gastrointestinal Disorders, fecal incontinence affects 6.9% of adult females and 7.4% of adult males. It has also been estimated that around 20.0% of people with irritable bowel syndrome have bowel incontinence.

In addition, different organizations such as United Ostomy Associations of America, Inc. and Colostomy U.K. are working towards raising awareness about ostomy. They are focused on empowering and supporting people who have had ostomy. Also, government bodies globally are introducing programs to provide support to individuals with a stoma by improving access to clinically appropriate and most suitable stoma-related products. These are some of the factors that are promoting the growth of the market.

Further key findings from the report suggest:
  • Colostomy bags were the largest segment in 2017 and are likely to witness the fastest growth over the forecast period due to factors such as their high usage rate and well-structured reimbursement policies across developed regions
  • The adult segment dominated the market in terms of revenue in 2017 owing to factors such as high prevalence of fecal incontinence among adults
  • The home care segment was the leading segment in the market in 2017, owing to rising adoption of bowel management products in home care settings. The segment is also poised to witness the highest CAGR during the forecast period
  • North America and Europe accounted for sizeable cumulative share in the market in 2017. These regions experience high usage rate of bowel management systems and are marked by presence of significant key players such as 3M and Medtronic
  • Asia Pacific is expected to exhibit the fastest growth during the forecast period due to unmet clinical needs and need for better diagnosis
  • Some of the prominent players operating in this space are Mederi Therapeutics Inc.; Aquaflush Medical Limited; Medtronic; Coloplast; C.R. Bard; 3M; Consure Medical; B. Braun; Cogentix Medical; ConvaTec; Axonics Modulation Technologies; Welland Medical Limited; MBH-International A/S; and Wellspect HealthCare
  • Key players are adopting strategies such as expanding their geographic reach, increasing R&D activities, rising number of collaborations, growing awareness programs, technological advancements, and launching new products to increase their market share.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M
  • B. Braun
  • Cogentix Medical
  • Consure
  • Hollister Incorporated
  • Medtronic
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Information procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.2 Research methodology
1.3 Geographic scope & assumptions
1.4 Global market calculation
1.4.1 Global market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Segment share calculation
1.6 Primary sources
1.7 List of secondary sources

Chapter 2 Executive Summary
2.1 Market snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market driver analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Introduction of technologically advanced products
3.1.1.3 Increasing prevalence of fecal incontinence
3.1.2 Market restraint analysis
3.1.2.1 Discomfort related to the use of bowel management systems
3.2 Penetration & growth prospect mapping
3.3 Bowel management systems market - SWOT analysis, By factor (political & legal, economic and technological)
3.4 Industry analysis - Porter’s

Chapter 4 Bowel Management Systems Market: Product Estimates & Trend Analysis
4.1 Bowel management systems market: Product movement analysis
4.2 Colostomy bags
4.2.1 Colostomy bags market, 2014 - 2025 (USD Million)
4.3 Irrigation systems
4.3.1 Irrigation systems market, 2014 - 2025 (USD Million)
4.4 Nerve modulation devices
4.4.1 Nerve modulation devices market, 2014 - 2025 (USD Million)
4.5 Others
4.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 5 Bowel Management Systems Market: Patient Type Estimates & Trend Analysis
5.1 Bowel management systems market: Patient Types movement analysis
5.2 Adult
5.2.1 Adult market, 2014 - 2025 (USD Million)
5.3 Pediatric
5.3.1 Pediatric market, 2014 - 2025 (USD Million)

Chapter 6 Bowel Management Systems Market: End-use Estimates & Trend Analysis
6.1 Bowel management systems market: End-use movement analysis
6.2 Home care
6.2.1 Home care market, 2014 - 2025 (USD Million)
6.3 Hospitals & ambulatory sugery centers
6.3.1 Hospitals & ambulatory sugery centers market, 2014 - 2025 (USD Million)

Chapter 7 Bowel Management Systems Market: Regional Outlook
7.1 Bowel management systems market share by region, 2017 & 2025 (USD Million)
7.2 North America
7.2.1 North America bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Germany bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.4.4 India
7.4.4.1 India bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa bowel management systems market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.2.1 Company profiles
8.2.2 Coloplast
8.2.2.1 Company overview
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 B. Braun
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 C. R. Bard
8.2.4.1 Company overview
8.2.4.2 Financial performance
8.2.4.3 Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5 Axonics Modulation Technologies
8.2.5.1 Company overview
8.2.5.2 Financial performance
8.2.5.3 Product benchmarking
8.2.5.4 Strategic initiatives
8.2.6 Aquaflush Medical Limited
8.2.6.1 Company overview
8.2.6.2 Financial performance
8.2.6.3 Product benchmarking
8.2.6.4 Strategic initiatives
8.2.7 Cogentix Medical
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.7.4 Strategic initiatives
8.2.8 Medtronic
8.2.8.1 Company overview
8.2.8.2 Financial performance
8.2.8.3 Product benchmarking
8.2.8.4 Strategic initiatives
8.2.9 3M
8.2.9.1 Company overview
8.2.9.2 Financial performance
8.2.9.3 Product benchmarking
8.2.9.4 Strategic initiatives
8.2.10 Consure
8.2.10.1 Company overview
8.2.10.2 Financial performance
8.2.10.3 Product benchmarking
8.2.10.4 Strategic initiatives
8.2.11 Hollister Incorporated
8.2.11.1 Company overview
8.2.11.2 Financial performance
8.2.11.3 Product benchmarking
8.2.11.4 Strategic initiatives
8.2.12 Convatec
8.2.12.1 Company overview
8.2.12.2 Financial performance
8.2.12.3 Product benchmarking
8.2.12.4 Strategic initiatives
8.2.13 Wellspect Healthcare
8.2.13.1 Company overview
8.2.13.2 Financial performance
8.2.13.3 Product benchmarking
8.2.13.4 Strategic initiatives
8.2.14 Welland Medical Limited
8.2.14.1 Company overview
8.2.14.2 Financial performance
8.2.14.3 Product benchmarking
8.2.14.4 Strategic initiatives
8.2.15 Mederi Therapeutics Inc.
8.2.15.1 Company overview
8.2.15.2 Financial performance
8.2.15.3 Product benchmarking
8.2.15.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4
  • Coloplast
  • B. Braun
  • C. R. Bard
  • Axonics Modulation Technologies
  • Aquaflush Medical Limited
  • Cogentix Medical
  • Medtronic
  • 3M
  • Consure
  • Hollister Incorporated
  • Convatec
  • Wellspect Healthcare
  • Welland Medical Limited
  • Mederi Therapeutics Inc.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll